Indonesia has entered the monitoring stage of phase three clinical trials for the Chinese-developed vaccine Sinovac. <br /><br />The monitoring phase is being conducted to determine the vaccine’s efficacy, immunogenicity and ensure its safety.<br /><br />WATCH MORE: https://thestartv.com/c/news<br />SUBSCRIBE: https://cutt.ly/TheStar<br />LIKE: https://fb.com/TheStarOnline
